Zymeworks Enters Global License and Collaboration Agreement With Roche for ZW209
Zymeworks announced an exclusive global license and collaboration agreement with Roche for ZW209, a trispecific T-cell engager targeting DLL3.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.